References
1. Demirkan FG, Doğan S, Kalyoncu Uçar A, Sönmez HE, Aktay Ayaz N.
Systemic lupus erythematosus complicated with Castleman disease: a
case-based review. Rheumatology international. 2021;41(2):475-9.
2. Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, et
al. Derivation and validation of the Systemic Lupus International
Collaborating Clinics classification criteria for systemic lupus
erythematosus. Arthritis and rheumatism. 2012;64(8):2677-86.
3. Gillmore R, Sin WY. Systemic lupus erythematosus mimicking lymphoma:
the relevance of the clinical background in interpreting imaging
studies. BMJ case reports. 2014;2014.
4. Scott GD, Kumar J, Oak JS, Boyd SD, Raess PW, Gratzinger DA.
Histology-Independent Signature Distinguishes Kikuchi-Fujimoto
Disease/Systemic Lupus Erythematosus-Associated Lymphadenitis From
Benign and Malignant Lymphadenopathies. American journal of clinical
pathology. 2020;154(2):215-24.
5. Xia JY, Chen XY, Xu F, Yang Y, Wang HY, Xue J. A case report of
systemic lupus erythematosus combined with Castleman’s disease and
literature review. Rheumatology international. 2012;32(7):2189-93.
6. De Marchi G, De Vita S, Fabris M, Scott CA, Ferraccioli G. Systemic
connective tissue disease complicated by Castleman’s disease: report of
a case and review of the literature. Haematologica. 2004;89(4):Ecr03.
7. Van de Voorde K, De Raeve H, De Block CE, Van Regenmortel N, Van
Offel JF, De Clerck LS, et al. Atypical systemic lupus erythematosus or
Castleman’s disease. Acta clinica Belgica. 2004;59(3):161-4.
8. Kojima M, Nakamura S, Morishita Y, Itoh H, Yoshida K, Ohno Y, et al.
Reactive follicular hyperplasia in the lymph node lesions from systemic
lupus erythematosus patients: a clinicopathological and
immunohistological study of 21 cases. Pathology international.
2000;50(4):304-12.
9. Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and
plasma-cell types of giant lymph node hyperplasia of the mediastinum and
other locations. Cancer. 1972;29(3):670-83.
10. Castleman B, Towne VW. Case records of the Massachusetts General
Hospital: Case No. 40231. The New England journal of medicine.
1954;250(23):1001-5.
11. Kessler E. Multicentric giant lymph node hyperplasia. A report of
seven cases. Cancer. 1985;56(10):2446-51.
12. van Rhee F, Oksenhendler E, Srkalovic G, Voorhees P, Lim M,
Dispenzieri A, et al. International evidence-based consensus diagnostic
and treatment guidelines for unicentric Castleman disease. Blood
advances. 2020;4(23):6039-50.
13. Kojima M, Nakamura S, Itoh H, Yoshida K, Asano S, Yamane N, et al.
Systemic lupus erythematosus (SLE) lymphadenopathy presenting with
histopathologic features of Castleman’ disease: a clinicopathologic
study of five cases. Pathology, research and practice.
1997;193(8):565-71.
14. Zhang L, Jiao L, Wang SJ. Successful Treatment with Rituximab in a
Patient with Castleman’s Disease Complicated by Systemic Lupus
Erythematosus and Severe Autoimmune Thrombocytopenia. Chinese medical
journal. 2015;128(18):2551-2.
Table 1. Laboratory parameters of the patient